Prestations médicales
Enseignement et formation
Research projects and facilities
| home < Research projects and facilities < Clinical pharmacology of new anticancer agents < Imatinib Concentration Monitoring Evaluation < Contact & investigators |     |
| Imatinib Concentration Monitoring Evaluation |
|
| Why monitoring in the scope of a study? |
|
| Practical information |
|
| Study documents |
|
| Contact & investigators |
|
| Related publications |
|
| Abstracts |
|
Imatinib Concentration Monitoring Evaluation (I-COME)
Investigators
| Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne: |
|
T. Buclin (PI), L.A. Decosterd (lab head), N. Widmer, C. Csajka, V. Gotta (Division de Pharmacologie et Toxicologie cliniques), M. Duchosal (Service d’Hématologie et Laboratoire Central d’Hématologie) |
| Hôpitaux Universitaires de Genève: |
| Y. Chalandon (Service d’Hématologie) |
| Universitätsspital Basel: |
| D. Heim (Hämatologie) |
| Kantonsspital Luzern: |
| M. Gregor (Hämatologische Abteilung) |
Respondents for other regions
| Spital Thurgau: |
| R. Benz (Innere Medizin/Onkologie) |
| Ospedale Regionale Bellinzona, Ticino: |
| L. Leoncini-Franscini (Ematologia, Instituto Oncologico della Svizzera Italiana) |
| Inselspital Bern: |
| G.M. Baerlocher (Universitätsklinik für Hämatologie und Hämatologisches Zentrallabor) |
Contact
Verena Gotta
I-COME coordinator
Division of Clinical Pharmacology and Toxicology
Centre Hospitalier Universitaire Vaudois – CHUV
1011 Lausanne – SWITZERLAND
| tel.: +41 21 314 42 69 | e-mail: info@imatinib-monitoring.ch |
| fax.: +41 21 314 42 66 | website: www.imatinib-monitoring.ch |
|
|
